Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces International News Coverage on Benefits of CBD, U.N.'s Global CBD Policy

Medical Marijuana,Inc.
Posted on: 18 Dec 17
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces International News Coverage on Benefits of CBD, U.N.'s Global CBD Policy

PR Newswire

SAN DIEGO, Dec. 18, 2017

SAN DIEGO, Dec. 18, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Raúl Elizalde, President of subsidiary HempMeds® Mexico, was recently featured in several international news publications about his speaking engagement at the World Health Organization Drug Scheduling Convention on Psychotropic Substances in November 2017.

Elizalde, who's campaign to help his epileptic daughter legalized cannabidiol (CBD) in Mexico, discussed how the substance is non-psychoactive, non-addictive and has no negative side effects. He shared his story about how CBD changed his family's life for the better and how the World Health Organization's recommendation has the potential to change many more lives across the globe.

News publications Elizalde was featured in include:

"We couldn't be prouder to have Raúl representing the Medical Marijuana, Inc. portfolio of companies and to have our mission of increasing access to CBD featured in coverage on such prominent media outlets," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We believe that Raúl had a significant impact on the World Health Organization's recommendation not to schedule CBD and we're thankful that the media continues to view him as an important cannabis industry icon. Medical Marijuana, Inc. continues to be a leader for the industry, and the future is very bright indeed."

About HempMeds® Mexico
HempMeds® Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company's website at: http://www.hempmeds.mx.

About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P: 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com

View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-subsidiary-hempmeds-mexico-announces-international-news-coverage-on-benefits-of-cbd-uns-global-cbd-policy-300572349.html

SOURCE Medical Marijuana, Inc.

PR Newswire
www.prnewswire.com

Last updated on: 18/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.